Article Details

FDA Approves Biocon Biologics' Denosumab Biosimilars: Bosaya and Aukelso

Retrieved on: 2025-09-18 15:52:38

Tags for this article:

Click the tags to see associated articles and topics

FDA Approves Biocon Biologics' Denosumab Biosimilars: Bosaya and Aukelso. View article details on hiswai:

Excerpt

Denosumab is a human monoclonal antibody that works by targeting RANKL, a protein essential for the formation and survival of osteoclasts, which are ...

Article found on: www.centerforbiosimilars.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo